TRANSLATIONAL RESEARCH

Natural stilbenes in prostate cancer targeted interception and therapy: pre-clinical studies

Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer

Treatment response and survival of patients with early-onset compared to older-onset colorectal cancer in the Netherlands

SWOT Analysis for Maintaining the Sustainability of Newly Established Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia

Breast cancer immunotherapy using magnetised oncolytic virus

In vitro strategy to discover therapeutic targets in PDAC

Protein Tyrosine Phosphatase Receptor type Psi (PTPRU) in clinical breast cancer

Ovarian cancer Zebrafish Avatars for personalized multiple drug testing

Malignant Ascites Derived Organoids from Ovarian Cancer Patients for Understanding Platinum Resistance and Approaching Targeted Therapy

BQ323636.1 Overexpression Drives mTOR Signaling and Lipid Metabolism via ACSL4 in ER-positive Breast Cancer

Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol (DRUP)

Investigating the Therapeutic and Prognostic Utility of Long Non-Coding RNA Targets and their Association with Tumour Microenvironment in KRAS-Mutant NSCLC

Canine Melanoma as a Translational Model for Novel Immuno-Nanotherapy and Focal Adhesion Kinase-targeted Strategies in Human Oncology

Detection of low frequency variants from low input FFPE samples with comprehensive tumor/normal exome sequencing

M2 macrophages promote survival and proliferation of patient-derived gastric cancer organoids in a tumor biology-dependent manner

Single-cell spatial atlas of high-grade serous ovarian cancer unveils MHC class II as a key driver of spatial tumor ecosystems and clinical outcomes

Exosomes from urine: A multi-purpose system for urine liquid biopsy

PET imaging of PD1-positive MOLT-4 T-cell lymphoblastic leukemia tumours in NRG mice using 89Zr-labeled pembrolizumab

Beating Breast Cancer Brain Metastases: Leverage Nano-Immunotherapy to Re-educate Host Immunity

PET-based and glycolytic biomarkers reveal 18F-FDG uptake/heterogeneity phenotypes and predict metabolically active disease in aggressive B-cell lymphomas

Engineered v5 PE6A-VLPs Enable In Vivo PCSK9 Gene Editing to Suppress Hepatocellular Carcinoma Progression and Modulate Cholesterol Metabolism

Whole exome sequencing of non-small cell lung cancers in a cohort of patients enriched for genetic tumor risk

Improving intraoperative tumor margin assessment in lung cancer surgeries using the MasSpec Pen technology

Enhancing Anti-Tumor Activity in Pancreatic Cancer by Targeting PI3Kδ and Autotaxin

Loss of the tumor suppressor NUMB drives aggressive bladder cancer via hyperactivation of the RHOA-ROCK-YAP pathway: implications for personalized prognosis and targeted therapy

Innovative Multiomic Spatial Biology Assay for Comprehensive Immune Profiling of the Tumor Microenvironment

Artificial intelligence predicts prognostic features of patient survival related to microvascular invasion and molecular classes of hepatocellular carcinoma

Preclinical combination of selenium nanoparticles and a nanovaccine demonstrates immunotherapeutic properties against luminal B breast cancer

Hyaluronic Acid-Coated Nanoparticles for Targeted Delivery in Colorectal Cancer: Unlocking the Potential of CD44-Dependent Therapy

Building precision oncology via real-world data standardization, privacy preserving infrastructures, and collaboration among IT and clinical experts: TheDIGICORE network experience

3D printing in microfluidic device prototyping for cancer research

Characterisation of the Colon Adenocarcinoma microenvironment with a focus on Natural Killer Cells

Tissue-Engineered Human 3D Tumor Models for Predictive Preclinical Anti-Cancer Therapy Assessment

Organotypic Slice Cultures as a Feasible Predictive Model for Carboplatin Response in High-Grade Serous Ovarian Cancer (TOSCA Study)

A systematic review of Cancer spontaneous remission (CSR) and post-radiation abscopal responses (p-rAR)